3.77
-0.17 (-4.31%)
| Penutupan Terdahulu | 3.94 |
| Buka | 3.93 |
| Jumlah Dagangan | 6,557,766 |
| Purata Dagangan (3B) | 3,766,572 |
| Modal Pasaran | 437,211,168 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.98 |
| Harga / Jualan (P/S) | 0.180 |
| Harga / Buku (P/B) | 0.800 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -4.54% |
| Margin Operasi (TTM) | 0.35% |
| EPS Cair (TTM) | -1.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -24.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 77.09% |
| Nisbah Semasa (MRQ) | 0.990 |
| Aliran Tunai Operasi (OCF TTM) | 18.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.23 M |
| Pulangan Atas Aset (ROA TTM) | -0.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -9.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Menurun |
| Health Information Services (Global) | Menurun | Menurun | |
| Stok | Evolent Health, Inc | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.55% |
| % Dimiliki oleh Institusi | 108.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cadian Capital Management, Lp | 30 Sep 2025 | 11,728,924 |
| Rubicon Founders Llc | 30 Sep 2025 | 5,816,123 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 10.00 (Citizens, 165.25%) | Beli |
| Median | 5.50 (45.89%) | |
| Rendah | 3.00 (RBC Capital, -20.42%) | Pegang |
| Purata | 5.75 (52.52%) | |
| Jumlah | 7 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 3.37 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Oppenheimer | 02 Mar 2026 | 6.00 (59.15%) | Beli | 3.58 |
| Citigroup | 26 Feb 2026 | 4.00 (6.10%) | Beli | 3.32 |
| 09 Jan 2026 | 6.00 (59.15%) | Beli | 4.17 | |
| Truist Securities | 26 Feb 2026 | 6.00 (59.15%) | Beli | 3.32 |
| UBS | 26 Feb 2026 | 5.00 (32.63%) | Beli | 3.32 |
| BTIG | 25 Feb 2026 | 8.00 (112.20%) | Beli | 3.14 |
| 02 Feb 2026 | 10.00 (165.25%) | Beli | 3.26 | |
| Needham | 25 Feb 2026 | 4.00 (6.10%) | Beli | 3.14 |
| RBC Capital | 25 Feb 2026 | 3.00 (-20.42%) | Pegang | 3.14 |
| Citizens | 06 Jan 2026 | 10.00 (165.25%) | Beli | 4.02 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 |
| 02 Jan 2026 | Pengumuman | Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |